Gilead Sciences (GILD) EBIT Margin (QoQ) (2009 - 2026)

Gilead Sciences (GILD) EBIT Margin (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 96,436,181.12 Bn 96,436,176.16 Bn 7.76 Bn
2 Eli Lilly 1,017.30 Bn 1,012.01 Bn 16.22 Bn
3 Johnson & Johnson 579.61 Bn 557.55 Bn 15.96 Bn
4 AbbVie 402.30 Bn 392.96 Bn 10.78 Bn
5 Merck 294.24 Bn 288.59 Bn 12.09 Bn
6 Amgen 191.82 Bn 179.78 Bn 5.87 Bn
7 Gilead Sciences 155.93 Bn 148.21 Bn 5.52 Bn
8 Pfizer 149.05 Bn 136.28 Bn -1.21 Bn
9 Bristol Myers Squibb 116.33 Bn 105.88 Bn 8.07 Bn
10 Novartis Ag 112.59 Bn 111.90 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1,212.00
Dec 31, 2025 -1,779.00
Sep 30, 2025 789.00
Jun 30, 2025 138.00
Mar 31, 2025 116.00
Dec 31, 2024 2,063.00
Sep 30, 2024 -2,625.00
Jun 30, 2024 10,266.00
Mar 31, 2024 -8,730.00
Dec 31, 2023 -1,454.00
Sep 30, 2023 1,197.00
Jun 30, 2023 -161.00
Mar 31, 2023 -384.00
Dec 31, 2022 -961.00
Sep 30, 2022 787.00
Jun 30, 2022 2,942.00
Mar 31, 2022 -999.00
Dec 31, 2021 -3,880.00
Sep 30, 2021 1,565.00
Jun 30, 2021 -887.00